Browse Category

NYSE:KMB News 8 January 2026 - 21 January 2026

Kenvue stock steadies as Kimberly-Clark deal vote nears, with lawsuits in the mix

Kenvue stock steadies as Kimberly-Clark deal vote nears, with lawsuits in the mix

NEW YORK, Jan 21, 2026, 09:46 EST — Regular session Kenvue Inc shares edged down roughly 0.1% to $17.58 in early Wednesday trading, while Kimberly-Clark, the potential buyer, held steady at $101.44. The modest uptick followed Wall Street’s biggest drop in three months, as the market opened higher while investors digested President Donald Trump’s comments at the World Economic Forum in Davos. (Reuters) For Kenvue, the immediate focus isn’t so much on toothpaste or painkillers, but rather on deal dynamics. Activist investors are increasingly pushing boards to consider sales and breakups, and Kenvue shows how that pressure can trigger a
Kenvue stock ticks up as investors size up Kimberly-Clark takeover vote in days

Kenvue stock ticks up as investors size up Kimberly-Clark takeover vote in days

New York, Jan 20, 2026, 11:04 AM EST — Regular session ongoing. Kenvue shares ticked up 0.6% to $17.31 in late-morning trading Tuesday in New York, a modest gain as investors held back ahead of a late-January vote on the potential sale of the Tylenol and Band-Aid maker to Kimberly-Clark. The next nine days are critical since the deal stands as the clearest near-term driver for Kenvue’s stock. Investors are pricing the shares almost like a vote on the likelihood of the merger closing—and what the company’s value might be if the transaction stalls or falls through. (SEC) Kenvue shareholders
Johnson & Johnson stock heads into earnings after a mild dip — what could move JNJ next

Johnson & Johnson stock heads into earnings after a mild dip — what could move JNJ next

New York, Jan 18, 2026, 10:37 EST — Market closed. Johnson & Johnson shares slipped 0.4% to $218.66 on Friday, the last session before U.S. markets shut for the Martin Luther King Jr. Day holiday. (Yahoo Finance) The stock heads into the week with investors leaning hard on earnings to justify valuations. “The most important thing right now is earnings,” said Chris Fasciano, chief market strategist at Commonwealth Financial Network. (Reuters) On Friday, U.S. stocks ended nearly flat in choppy trade, while the S&P 500 health care sector fell 0.8%, a bigger drop than the broader market. “We’re at the
Kenvue stock has a new catalyst: ISS backs Kimberly-Clark merger ahead of Jan. 29 vote

Kenvue stock has a new catalyst: ISS backs Kimberly-Clark merger ahead of Jan. 29 vote

New York, Jan 18, 2026, 05:48 EST — Market closed Kenvue (KVUE) shares slipped 0.35% to close at $17.20 on Friday, as investors digested a crucial nod for its planned sale to Kimberly-Clark. Proxy adviser Institutional Shareholder Services gave the green light, saying “on balance, support for the transaction is warranted.” Still, ISS flagged ongoing market jitters and legal risks as key concerns for shareholders. With proxy advisers often influencing big institutional votes, both companies’ investors are set to weigh in on Jan. 29. (Reuters) The timing is tight and inconvenient. U.S. stock markets are closed for the weekend and
Kenvue stock: ISS backs Kimberly-Clark deal as lawsuit filings add pressure ahead of vote

Kenvue stock: ISS backs Kimberly-Clark deal as lawsuit filings add pressure ahead of vote

New York, Jan 17, 2026, 07:00 (EST) — Market closed. Kenvue Inc shares ended slightly lower on Friday after proxy adviser ISS backed Kimberly-Clark’s takeover proposal, keeping attention on a shareholder vote later this month. The broader market went into the long weekend on a quiet note, with the S&P 500 down 0.06% on Friday. U.S. stock markets are closed on Monday for the Martin Luther King Jr. holiday. (Reuters) ISS said “support for the transaction is warranted,” while flagging what it called a “sustained negative market reaction” and uncertainty tied to litigation around Kenvue products. Kimberly-Clark proposed buying Tylenol-maker
Kenvue stock is up today — here’s what the Kimberly-Clark deal is worth now

Kenvue stock is up today — here’s what the Kimberly-Clark deal is worth now

New York, January 15, 2026, 11:16 EST — Regular session. Kenvue Inc shares rose about 0.5% to $17.21 on Thursday, as Kimberly-Clark — the would-be buyer — gained roughly 0.7% to $99.81, lifting the implied value of the takeover offer. The broader market was firmer, with the S&P 500’s main ETF up about 0.6%, while the consumer staples ETF was little changed. This matters now because KVUE has been trading like a deal stock. The cash part is fixed, but the stock part moves every time Kimberly-Clark moves. It leaves investors focused on the “spread” — the gap between Kenvue’s
Kenvue stock edges up as Kimberly-Clark vote nears — the deal spread traders are watching

Kenvue stock edges up as Kimberly-Clark vote nears — the deal spread traders are watching

New York, Jan 14, 2026, 11:12 EST — Regular session Kenvue Inc shares ticked up roughly 0.4% to $17.08 on Wednesday, continuing a stretch of modest fluctuations as the stock moves mainly on deal speculation. The gain followed Kimberly-Clark’s submission of extra documents to the U.S. Securities and Exchange Commission related to its intended purchase of the consumer health firm. Timing is key. Kenvue shareholders will vote on the deal on Jan. 29 at 9:00 a.m. ET, with most ballots expected by the night before, per the deal site. (leadinghealthandwellness.com) Under the deal, Kenvue shareholders will get $3.50 in cash
Kenvue stock (KVUE) ends week lower as Jan. 29 Kimberly-Clark deal vote nears

Kenvue stock (KVUE) ends week lower as Jan. 29 Kimberly-Clark deal vote nears

New York, January 11, 2026, 18:45 EST — Market closed Kenvue Inc shares slipped on Friday, closing down about 1% at $16.83, as traders headed into the weekend still pricing in a gap to Kimberly-Clark’s takeover terms. Kimberly-Clark shares ended down about 1% at $97.92. That gap has a date attached now. Stockholders of both companies are set to vote on the deal on Jan. 29 in separate virtual meetings, according to a joint proxy statement. Kenvue holders would receive $3.50 in cash and 0.14625 Kimberly-Clark shares per Kenvue share, a payout that rises or falls with Kimberly-Clark’s stock; Kenvue’s
Kenvue stock lags Kimberly-Clark offer value as deal vote and earnings line up

Kenvue stock lags Kimberly-Clark offer value as deal vote and earnings line up

New York, January 11, 2026, 06:15 EST — Market closed. Kenvue Inc shares slipped about 1% on Friday to close at $16.83, with volume of about 57.5 million shares, Nasdaq data showed. The stock finished the week still trading below the value implied by Kimberly-Clark’s agreed buyout. (Nasdaq) The market is shut on Sunday, but KVUE is being traded like a deal stock now. With a late-January vote on deck and earnings around the corner, the spread has become the quick read on whether investors think the transaction closes cleanly — and on time. Kimberly-Clark and Kenvue agreed in November
Kenvue stock countdown: Jan. 29 merger vote looms as KVUE deal spread stays jumpy

Kenvue stock countdown: Jan. 29 merger vote looms as KVUE deal spread stays jumpy

NEW YORK, Jan 10, 2026, 08:01 (ET) — Market closed Kenvue Inc (KVUE) shares slipped 0.9% on Friday, ending at $16.83 after trading between $16.75 and $17.05, retracing some of Thursday’s gains. The Options Clearing Corporation highlighted a shareholder vote set for Jan. 29 on Kenvue’s proposed merger with Kimberly-Clark and detailed a planned adjustment to KVUE options once the deal closes. They warned terms might shift as new details emerge. (InfoMemo) Markets closed over the weekend, but KVUE is once again behaving like a deal stock. The key date ahead is the Jan. 29 vote, while merger-arbitrage funds keep
Kenvue stock: Options memo spotlights Jan. 29 vote on Kimberly-Clark deal

Kenvue stock: Options memo spotlights Jan. 29 vote on Kimberly-Clark deal

New York, January 9, 2026, 21:05 EST — Market closed. The Options Clearing Corporation on Friday announced a planned adjustment for Kenvue Inc. options before the Jan. 29 shareholder vote on the company’s proposed merger with Kimberly-Clark. Kenvue shares last changed hands at $16.83, slipping roughly 1% after U.S. markets closed. (InfoMemo) Why it matters now: Kenvue (KVUE) has become a merger-arbitrage play, with investors valuing the stock based on the offer price and the likelihood the deal goes through. The OCC memo dives into that trade but also clarifies what options contracts would actually deliver if the merger closes
Kenvue (KVUE) stock nudges up as fresh deal scrutiny hits — and the spread traders are watching

Kenvue (KVUE) stock nudges up as fresh deal scrutiny hits — and the spread traders are watching

New York, Jan 8, 2026, 10:57 EST — Regular session Kenvue Inc shares rose 0.8% to $16.87 in mid-morning trade on Thursday after shareholder law firm Kahn Swick & Foti said it was investigating the consumer health group’s pending sale to Kimberly-Clark. The firm said it is reviewing whether Kenvue’s board ran a fair process and secured the best price for shareholders. PR Newswire The move matters now because Kenvue’s stock has been trading like a deal situation, not a stand-alone story, as investors handicap closing odds and timing. Merger arbitrage — buying the target while hedging the buyer —

Stock Market Today

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 07.02.2026

7 February 2026
LIVEMarkets rolling coverageStarted: February 7, 2026, 12:00 AM ESTUpdated: February 7, 2026, 1:01 AM EST Crude Oil Prices Rise on Dollar Weakness, Geopolitical Tensions February 7, 2026, 12:52 AM EST. Crude oil prices edged higher on Friday, supported by a weaker U.S. dollar and escalating geopolitical risks in the Middle East. March WTI crude gained 0.41%, rebounding from early losses, while gasoline prices rose 1.38%. Doubts over a U.S.-Iran nuclear deal loom after reports of Iran's refusal to halt uranium enrichment, raising the risk of military action and potential disruption of vital shipping routes. Additionally, a surge in U.S. consumer
Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
Go toTop